ストックスクリーナーアプリを入手
17.43
0.23%
0.04
アフターアワーズ：
17.43
前日終値:
$17.39
開ける：
$17.95
24時間の取引高:
83,042
Relative Volume:
1.14
時価総額：
$255.27M
収益：
$166.88M
当期純損益:
$-74.18M
株価収益率:
-3.4379
EPS:
-5.07
ネットキャッシュフロー:
$1.14M
1週間 パフォーマンス:
-2.41%
1か月 パフォーマンス:
+6.87%
6か月 パフォーマンス:
-31.89%
1年 パフォーマンス:
-32.68%
1日の値動き範囲:
$17.32
$18.07
1週間の範囲:
$17.32
$18.34
52週間の値動き範囲:
$15.40
$29.11
Anika Therapeutics Inc Stock (ANIK) Company Profile
名前
Anika Therapeutics Inc
セクター
電話
(781) 457-9000
住所
32 WIGGINS AVENUE, BEDFORD, MA
ANIK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
17.43 | 255.27M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-01 | 繰り返されました | Barrington Research | Outperform |
| 2023-08-14 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | 再開されました | Stephens | Equal-Weight |
| 2022-03-09 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | 開始されました | Stephens | Overweight |
| 2021-07-16 | 開始されました | UBS | Neutral |
| 2020-12-16 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | アップグレード | Sidoti | Neutral → Buy |
| 2020-01-10 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | 開始されました | BWS Financial | Sell |
| 2019-09-24 | 繰り返されました | Barrington Research | Outperform |
| 2019-09-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | ダウングレード | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2018-07-27 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | 繰り返されました | Barrington Research | Outperform |
| 2016-05-09 | アップグレード | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Anika Therapeutics Inc (ANIK) 最新ニュース
Comparing Lyra Therapeutics (NASDAQ:LYRA) & Anika Therapeutics (NASDAQ:ANIK) - Defense World
How to Take Advantage of moves in (ANIK) - Stock Traders Daily
SG Americas Securities LLC Reduces Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Global Hyaluronic Acid for Osteoarthritis Market Reached - openPR
Viscosupplementation Market Global Forecast Report and Company Analysis 2025-2033 Featuring Anika Therapeutics, Zimmer Biomet, Smith & Nephew, F.Hoffmann-La Roche, Sanofi, Chugai, Lifecore, LGResearchAndMarkets.com | FinancialContent Busi - Financial Content
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%? - Yahoo Finance
BlackRock, Inc. Reduces Stake in Anika Therapeutics Inc - GuruFocus.com
Trading (ANIK) With Integrated Risk Controls - news.stocktradersdaily.com
JPMorgan Chase & Co. Sells 11,072 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Dimensional Fund Advisors LP Reduces Stake in Anika Therapeutics Inc - GuruFocus.com
Facial Aesthetics Market Generated Opportunities, Future - openPR
Orthopedic Digit Implants Market: Share, Revenue Insights, - openPR
Barclays PLC Purchases 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Viscosupplementation Market Generated Opportunities, Future - openPR
(ANIK) Proactive Strategies - Stock Traders Daily
Anika Therapeutics stock hits 52-week low at $15.8 By Investing.com - Investing.com Australia
Anika Therapeutics stock hits 52-week low at $15.8 - Investing.com India
Jane Street Group LLC Increases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Geode Capital Management LLC - Defense World
Barclays PLC Buys 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
We Think Anika Therapeutics (NASDAQ:ANIK) Can Easily Afford To Drive Business Growth - Yahoo Finance
State Street Corp Sells 7,667 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by HighTower Advisors LLC - Defense World
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Anika Therapeutics to Present at JPM Healthcare Conference 2025: Joint Preservation Leader Takes Stage - StockTitan
(ANIK) On The My Stocks Page - Stock Traders Daily
Fmr LLC Acquires 4,996 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Improved Revenues Required Before Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Find Their Feet - Simply Wall St
Anika Therapeutics stock hits 52-week low at $15.99 - Investing.com
Verition Fund Management LLC Sells 1,763 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update - MarketBeat
Knee Osteoarthritis Market Projected CAGR 12.5% Dynamics - openPR
Joint Pain Injection Market Expected to Reach Prominent Growth - openPR
ANIK (Anika Therapeutics) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.
Anika To Participate in December 2024 Investor Conferences - The Manila Times
Anika Therapeutics to Present at Three Major Healthcare Investor Conferences in December | ANIK Stock News - StockTitan
Orthopedic Regenerative Surgical Products Market to Witness - openPR
Joint Pain Injection Market Size, Share, Trends, - openPR
New Strong Sell Stocks for November 11th - Yahoo Canada Finance
Orthobiologics Market Size, Growth, Opportunities 2024-2032 | - openPR
Anika Therapeutics Navigates Geopolitical Risks Amid Global Conflicts - TipRanks
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Capital Management Corp VA - MarketBeat
Anika Therapeutics Announces Third Quarter Financial ResultsOn October 31, 2024, Anika Therapeutics, Inc. released a press statement unveiling its financial outcomes for the third quarter concluding on September 30, 2024. As per the report - Defense World
Viscosupplementation Market Report Analysis, Growth - openPR
Anika Therapeutics (NASDAQ:ANIK) Downgraded to Hold Rating by StockNews.com - MarketBeat
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call Transcript - Insider Monkey
Barrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $25.00 - Defense World
Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring By Investing.com - Investing.com South Africa
Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring - Investing.com
Anika Therapeutics Inc (ANIK) 財務データ
収益
当期純利益
現金流量
EPS
0.92%
1.31%
大文字化:
|
ボリューム (24 時間):